J M Wenzlau
Affiliation: University of Colorado Denver
- Novel diabetes autoantibodies and prediction of type 1 diabetesJanet M Wenzlau
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, 1775 Aurora Ct, Aurora, CO, 80045, USA
Curr Diab Rep 13:608-15. 2013..In this review, we summarize some of the salient properties of these targets that might contribute to their autoantigenicity and methods that have been used in attempts to identify new components of the humoral autoresponse. ..
- Development of a novel autoantibody assay for autoimmune gastritis in type 1 diabetic individualsJ M Wenzlau
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO 80045, USA
Diabetes Metab Res Rev 27:887-90. 2011..Parietal cell autoantibody detection via enzyme-linked immunosorbent assay is currently the most widely used biomarker of disease with diagnosis confirmed by subsequent immunohistochemistry via biopsy...
- Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjectsJ M Wenzlau
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado 80045, USA
J Clin Endocrinol Metab 95:4712-9. 2010..Zinc transporter 8 (ZnT8) is a newly discovered islet autoantigen in human type 1A diabetes (T1D)...
- Conserved epitopes in the protein tyrosine phosphatase family of diabetes autoantigensY Liu
Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado, USA
Ann N Y Acad Sci 1150:245-7. 2008..1% to FLYDA, and 33.7% to IDA. The majority of sera that bound FLYDA and/or IDA also recognized IA2. This raises the possibility that in some cases reactivity to IA2 may have arisen by molecular mimicry...